Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used as second-option medications when metformin fails. Variance of the glycated hemoglobin (HbA1c) response to DPP-4 inhibitions in patients with type 2 diabetes mellitus (T2DM) has been observed, but the characteristics which predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hao, Hu, Yun, Li, Feng-fei, Liu, Bing-li, Su, Xiao-fei, Ma, Jian-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118238/
https://www.ncbi.nlm.nih.gov/pubmed/27734321
http://dx.doi.org/10.1007/s13300-016-0200-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118238/
https://www.ncbi.nlm.nih.gov/pubmed/27734321
http://dx.doi.org/10.1007/s13300-016-0200-0

Ejemplares similares